SCHEMBL4766503

SCHEMBL4766503

OCC(Cc1c[nH]c2ccccc12)Nc1cc(-c2cccnc2)nc(-c2ccccn2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.47
CCND1 P24385 1/20 0.47
AKT1 P31749 9/20 0.44
NEK1 Q96PY6 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
ECE1 P42892 1/20 0.41
GBA1 P04062 1/20 0.41
DYRK3 O43781 1/20 0.40
ROCK2 O75116 1/20 0.40
PRKD3 O94806 1/20 0.40
PRKCG P05129 1/20 0.40
LCK P06239 1/20 0.40
CDK1 P06493 1/20 0.40
PIM1 P11309 1/20 0.40
PRKACA P17612 1/20 0.40
RPS6KB1 P23443 1/20 0.40
CDK2 P24941 1/20 0.40
AKT2 P31751 1/20 0.40
FLT4 P35916 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766487 1.00 CDK4 (0.47) CDK4CCND1AKT1NEK1KMT2A
SCHEMBL4773620 1.00 CDK4 (0.47) CDK4CCND1AKT1NEK1KMT2A
SCHEMBL4775038 0.88 CDK4 (0.47) CDK4CCND1AKT1KMT2AMEN1
SCHEMBL4776020 0.87 CDK4 (0.49) CDK4CCND1AKT1KMT2AMEN1
SCHEMBL4768727 0.86 TDP1 (0.51) CDK4CCND1AKT1KMT2AMEN1
SCHEMBL2240341 0.83 CDK4 (0.50) CDK4CCND1AKT1KMT2AMEN1
SCHEMBL4773513 0.82 CYP2A6 (0.44) KMT2AMEN1ECE1ROCK2PRKACA
SCHEMBL4775017 0.82 CYP2A6 (0.44) KMT2AMEN1ECE1ROCK2PRKACA
SCHEMBL4773536 0.82 CYP2A6 (0.44) KMT2AMEN1ECE1ROCK2PRKACA
SCHEMBL4773182 0.81 CYP2A6 (0.39) DYRK3PIM1CDK2DYRK1ACLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed